These observations suggest that the TSPX expression level could be correlated with cancer aggressiveness in lung adenocarcinoma, but not as pronounced in lung squamous cell carcinoma, making it a potential differentiating diagnostic/prognostic marker for the two subtypes of NSCLC. The gene discussed is TSPYL2; the disease is cancer.